Growth Metrics

AIM ImmunoTech (AIM) Shares Outstanding (Diluted Average) (2023 - 2024)

Historic Shares Outstanding (Diluted Average) for ImmunoTech (AIM) over the last 2 years, with Q4 2024 value amounting to $56.0 million.

  • ImmunoTech's Shares Outstanding (Diluted Average) rose 1529.57% to $56.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $56.0 million, marking a year-over-year increase of 1529.57%. This contributed to the annual value of $56.0 million for FY2024, which is 1529.57% up from last year.
  • According to the latest figures from Q4 2024, ImmunoTech's Shares Outstanding (Diluted Average) is $56.0 million, which was up 1529.57% from $48.6 million recorded in Q4 2023.
  • Over the past 5 years, ImmunoTech's Shares Outstanding (Diluted Average) peaked at $56.0 million during Q4 2024, and registered a low of $48.6 million during Q4 2023.